Home › Drug Product Listings

Drug Product Listings

Please note - this is not a complete list of products available in Canada. For a complete list of drug products marketed in Canada, visit the Health Canada Drug Product Database
A (37) | B (20) | C (24) | D (37) | E (40) | F (12) | G (11) | H (9) | I (24) | K (1) | L (26) | M (12) | N (7) | O (12) | P (28) | R (14) | S (27) | T (33) | U (4) | V (13) | W (2) | Z (4)
Generic Namesort icon Common Trade Name(s) Classification Date Marketed in Canada (yyyy/mm/dd)
Ruxolitinib Jakavi Antineoplastic agent 2012/07/18
Rupatadine Rupall Antihistamine, second generation 2017/01/25
Rufinamide Banzel Antiepileptic 2011/09
Rotigotine Neupro Antiparkinsonian agent / Dopamine agonist 2013/09/12
Rosiglitazone + glimepiride Avandaryl 2011/03/31
Romosozumab Evenity Bone formation agent 2019/08/12
Roflumilast Daxas Phosphodiesterase 4 (PDE4) Inhibitor 2010/11/25
Risedronate sodium Actonel Bisphosphonate
Risedronate + Calcium carbonate Actonel APC
Risedronate Actonel DR Bone metabolism regulator 2011/09/28
Risankizumab Skyrizi Interleukin-23 inihbitor 2019/05/13
Rilpivirine Edurant Antiviral agent 2011/08/08
Ribociclib Kisqali Antineoplastic agent 2018/11/26
Regorafenib Stivarga Antineoplastic agent 2013/03/11
Syndicate content